As a President within Lumanity’s Asset Optimization & Commercialization practice in the US, Angie’s role includes partnering with the life sciences industry to provide deep understanding, leverage insights, and identify opportunity to drive product optimization and shape commercialization strategy. Her passion is elevating the voice of the consumer by capturing, communicating and contextualizing their needs and experiences to improve health and accelerate access to medical advances.
Angie has over 20 years of marketing research experience, with the majority dedicated to the life sciences industry. She leads a team of qualitative, quantitative and user experience specialists, utilizing innovative methodologies, but enjoys reclaiming her quantitative roots on occasion. She has worked across a wide variety of therapeutic categories, with extensive experience in rare disease, neurology, pulmonology, immunology, hematology, and mental health.
Prior to joining Cello Health Insight (now Lumanity) in 2013, her marketing research career included being a Partner at Hall & Partners Research (2005–2013), Vice President at Research International (2000–2005), Q2 Marketing Research (1997–2000) and Futuro, A Beiersdorf Company (1995–1997).